Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11125-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11125-1-AP, RRID:AB_2201727
- Product name
- TESC antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TESC antibody (Cat. #11125-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
TESC promotes differentiated thyroid cancer development by activating ERK and weakening NIS and radioiodine uptake.
The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma.
Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.
Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis.
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer.
CHP1-mediated NHE1 biosynthetic maturation is required for Purkinje cell axon homeostasis.
Dong Y, Fan B, Li M, Zhang J, Xie S, Di S, Jia Q, Gong T
Pathology, research and practice 2024 Jan;253:154964
Pathology, research and practice 2024 Jan;253:154964
TESC promotes differentiated thyroid cancer development by activating ERK and weakening NIS and radioiodine uptake.
Guo Y, Cai Y, Song F, Zhu L, Hu Y, Liu Y, Ma W, Ge J, Zeng Q, Ding L, Li L, Zheng G, Ge M
Endocrine 2023 Sep;81(3):503-512
Endocrine 2023 Sep;81(3):503-512
The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma.
Cao Y, Ye D, Shen Z, Li Z, Li Q, Rong H
Frontiers in oncology 2022;12:769666
Frontiers in oncology 2022;12:769666
Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
Zou X, Zhou Q, Nie Y, Gou J, Yang J, Zhu J, Li Z, Gong Y
BMC cancer 2022 May 31;22(1):595
BMC cancer 2022 May 31;22(1):595
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
Zhou ZG, Chen JB, Zhang RX, Ye L, Wang JC, Pan YX, Wang XH, Li WX, Zhang YJ, Xu L, Chen MS
Cancer communications (London, England) 2020 Aug;40(8):355-369
Cancer communications (London, England) 2020 Aug;40(8):355-369
TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.
Hsieh CH, Chu CY, Lin SE, Yang YSH, Chang HS, Yen Y
Cancers 2020 Apr 29;12(5)
Cancers 2020 Apr 29;12(5)
Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.
Kim TW, Han SR, Kim JT, Yoo SM, Lee MS, Lee SH, Kang YH, Lee HG
Oncology reports 2019 Jun;41(6):3464-3474
Oncology reports 2019 Jun;41(6):3464-3474
Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis.
Fan J, Xing Y, Wen X, Jia R, Ni H, He J, Ding X, Pan H, Qian G, Ge S, Hoffman AR, Zhang H, Fan X
Genome biology 2015 Jul 14;16(1):139
Genome biology 2015 Jul 14;16(1):139
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer.
Kang YH, Han SR, Kim JT, Lee SJ, Yeom YI, Min JK, Lee CH, Kim JW, Yoon SR, Yoon DY, Hong KS, Hwang GS, Kim HC, Lee YH, Lee HG
Oncotarget 2014 Apr 30;5(8):2149-60
Oncotarget 2014 Apr 30;5(8):2149-60
CHP1-mediated NHE1 biosynthetic maturation is required for Purkinje cell axon homeostasis.
Liu Y, Zaun HC, Orlowski J, Ackerman SL
The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Jul 31;33(31):12656-69
The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Jul 31;33(31):12656-69
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 11125-1-AP(TESC antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TESC antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TESC. This antibody recognizes human, mouse, rat antigen. The TESC antibody has been validated for the following applications: ELISA, WB, IHC analysis.
